ProKidney

ProKidney

The development of a cell therapy candidate that has the potential to improve the lives of patients with chronic kidney disease.

HQ location
Winston-Salem, United States
Launch date
Market cap
$337m
Enterprise value
$47m
Share price
$2.50 PROK
Authorizing premium user...